IRVINE, Calif., July 30, 2015 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, today announced
that Robert A. Ingram has retired
from the company's Board of Directors.
"Bob is an ardent champion for innovation in the lifesciences
industry, and it has been a true privilege to have him on Edwards'
board as we pursue our focused innovation strategy," said
Michael A. Mussallem, Edwards'
chairman and CEO. "Bob has provided a valuable perspective to
our board, drawing on his experience and extensive relationships as
a global leader for the pharmaceutical industry. We are deeply
grateful for his years of service, his focus on patients and his
thoughtful guidance to Edwards, and wish him all the best in the
future."
Ingram joined Edwards' board in 2003 and has chaired the
Compensation and Governance Committee, as well as served on the
Audit Committee.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of
heart valves and hemodynamic monitoring. Driven by a passion
to help patients, the company partners with clinicians to develop
innovative technologies in the areas of structural heart disease
and critical care monitoring, enabling them to save and enhance
lives. Additional company information can be found at
edwards.com.
Edwards, Edwards Lifesciences and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
Logo - http://photos.prnewswire.com/prnh/20140714/126903
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/edwards-announces-board-change-300121498.html
SOURCE Edwards Lifesciences Corporation